Explore more publications!

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on October 6, 2025

Kali Dental Expands Affordable Family Dentistry and Emergency Services in Huntington Beach, CA
California Riders Warned of Hidden Dangers When Motorcycles Hit Stalled Semi-Trucks
Dr. Jay Grossman Agrees: One in Three Young Adults Are Skipping the Dentist, And It Could Cost Them Their Health
UnitedLayer® Recognized as The Most Innovative Private Cloud Platform – USA 2025 by Global Tech Insider
Central California Alliance for Health launches TotalCare (HMO D-SNP)
Central California Alliance for Health lanza TotalCare (HMO D-SNP)
IN Fundraising Helps Non-Profits Secure Over $81M in Grant Funding
MOUNTRAX Prime Big Deal Days 2025: Spotlight on Acclaimed Foot Massagers
OmicInsight Appoints Jae Won Kim as Co-CEO to Drive Global Strategy and Partnerships
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
Biomea Fusion Announces Proposed Public Offering of Securities
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions